In vivo, AAV9‐mediated FBXO2 delivery attenuated disc degeneration in rats by suppressing ferroptosis and restoring collagen II expression, whereas FBXO2 KO accelerated IVDD via LCN2‐dependent pathways. This evidence concerns the gene FBXO2 and intervertebral disk degenerative disorder.